Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor Big-h3 via down regulation of its target gene, 18/April/2014, 22.23